SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 304.29 |
| Enterprise Value ($M) | 231.68 |
| Book Value ($M) | 162.62 |
| Book Value / Share | 8.80 |
| Price / Book | 1.87 |
| NCAV ($M) | 80.81 |
| NCAV / Share | 4.37 |
| Price / NCAV | 3.77 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.10 |
| Return on Assets (ROA) | 0.07 |
| Return on Equity (ROE) | 0.11 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.51 |
| Current Ratio | 2.44 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 163.53 |
| Assets | 245.33 |
| Liabilities | 82.72 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Paradigm Capital Management Inc/ny | 2.87 | -51.30 | |
| 13G/A | Prescott Group Capital Management, L.l.c. | 9.40 | 0.02 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,499 | 25,019 | 5.99 | |
| 2,620 | 33,324 | 7.86 | |
| 3,471 | 37,928 | 9.15 | |
| 2,298 | 20,413 | 11.26 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MTEM – Molecular Templates, Inc. | MTEX – Mannatech, Incorporated |
| MYNZ – Mainz Biomed N.V. | NERV – Minerva Neurosciences, Inc. |
| NKTR – Nektar Therapeutics |
Financial data and stock pages provided by
Fintel.io